We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Umuthi Healthcare Solutions Plc | LSE:UHS | London | Ordinary Share | GB00BJ56HG01 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 35.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMUHS
RNS Number : 1887I
Umuthi Healthcare Solutions PLC
10 August 2021
10 August 2021
Umuthi Healthcare Solutions PLC
("Umuthi" or the "Company" or the "Group")
Temporary Suspension - Further Update
The Board of Directors of Umuthi wishes to provide shareholders with a further update regarding the temporary suspension from trading in the Company's Ordinary Shares on the Standard Listing segment of the Official List of the UK Listing Authority.
As announced on 10 June 2021, the FCA temporarily suspended trading in the Company's shares as a result of its concerns regarding some Company shareholders who were involved in a share exchange agreement prior to the Company's Admission to trading, not being able to trade all of their shares. This was due, in some instances, to share trading accounts not having been fully activated.
Shareholders are referred to recent news announcements by the Financial Conduct Authority regarding a service provider utilised by Umuthi.
The Board wishes to assure shareholders that it has been continuing with its efforts to address the operational issues regarding the shares as raised by the FCA and has applied every effort to facilitate an expeditious restoration.
Any shareholders who may have questions that they need addressed, must please email info@umuthiplc.com to ensure such issues are addressed by management. Management are not in a position to address questions that are deemed inside information as regulated by Market Abuse Regulation Rules.
The Board will keep shareholders appraised of all developments and thank shareholders for their patience and support
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFLFFLTEIILIL
(END) Dow Jones Newswires
August 10, 2021 07:27 ET (11:27 GMT)
1 Year Umuthi Healthcare Soluti... Chart |
1 Month Umuthi Healthcare Soluti... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions